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Abstract
The genes alg-1 and alg-2 (referred to as ‘‘alg-1/2’’) encode the Argonaute proteins affiliated to the microRNA (miRNA)
pathway in C. elegans. Bound to miRNAs they form the effector complex that effects post-transcriptional gene silencing. In
order to define biological features important to understand the mode of action of these Argonautes, we characterize
aspects of these genes during development. We establish that alg-1/2 display an overlapping spatio-temporal expression
profile and shared association to a miRNAs set, but with gene-specific predominant expression in various cells and increased
relative association to defined miRNAs. Congruent with their spatio-temporal coincidence and regardless of alg-1/2 drastic
post-embryonic differences, only loss of both genes leads to embryonic lethality. Embryos without zygotic alg-1/2
predominantly arrest during the morphogenetic process of elongation with defects in the epidermal-muscle attachment
structures. Altogether our results highlight similarities and specificities of the alg-1/2 likely to be explained at different
cellular and molecular levels.
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Introduction
Argonaute family proteins are defined by the presence of the
PAZ domain which contributes to the binding of small (21–32
nucleotide long) RNA molecules and the PIWI domain that
confers the endonuclease enzymatic activity present in some
members of the Argonautes family [1]. This protein family is
conserved from archaea to eukarya, and largely expanded in some
plants and animals. Distinct kinds of small RNAs are bound by
Argonautes which participate in viral defence [2], post-transcrip-
tional gene regulation [3] and transposon silencing [4,5], processes
which in turn affect somatic and germline development.
In the nematode C. elegans, the Argonaute family comprises 24
genes and 2 pseudogenes, which partition into three groups, the
Argonaute-like (AGO-like), the Piwi-like and a nematode-specific
clade [1]. The genes alg-1 and alg-2 (hereafter, both referred to as
‘‘alg-1/2’’) belong to the conserved AGO-like clade, which
includes the fly D. melanogaster Ago1 and Ago2, and four
mammalian Argonautes, AGO1-4. Alg-1/2 have been shown to
be required for the miRNA pathway but not for exo-RNAi [6],
while the fly and mammalian AGOs are differentially required for
both RNAi and the miRNA pathway [7,8,9]. Two additional C.
elegans Argonautes in the same clade, alg-3 and alg-4, are required
for the accumulation of 26-nt long endogenous RNAs and affiliate
to a separate endo-RNAi pathway [10].
The canonical miRNA pathway involves the processing of a
primary RNA molecule by the RNase III enzyme Drosha, to
produce a stem-loop precursor molecule which is next cleaved by
the Dicer enzyme to release a small double-stranded RNA moiety
(21–23 nt). One of strands from this small duplex will then be
loaded into the Argonaute protein, forming the core complex that
targets the 39 untranslated region (UTR) of mRNAs with sequence
specificity to elicit post-transcriptional gene silencing [3].
In distinct organisms, multiple Argonautes are involved in the
miRNA pathway. In mammals, ectopic expression of the AGO1-4
Argonautes is able to provide miRNA function in cells [8], while fly
Ago1 is typically loaded with most miRNAs, some specific ones are
bound by Ago2 [9,11]. The presence of several Argonautes in the
miRNA pathway implies possible redundant and specialized
functions, an aspect still incompletely understood. In this report,
we describe the expression and embryonic phenotypes of C. elegans
alg-1/2 along with their post-embryonic miRNA interaction profiles
with the purpose of providing insights into the shared and the non-
redundant functions of the Argonautes of the miRNA pathway.
Results
Structural features of ALG-1 and ALG-2
The C. elegans genes alg-1 and alg-2 encode two Argonaute
proteins with high amino acid sequence similarity (81%; Fig. 1A).
PLoS ONE | www.plosone.org 1 March 2012 | Volume 7 | Issue 3 | e33750Figure 1. The C. elegans microRNA Argonautes alg-1 and alg-2. (A) Amino acid sequence alignment between ALG-1 and ALG-2 proteins (77%
identity and 81% similarity). Identical (black) and similar (grey) residues as well as the PAZ (pink) and PIWI (blue) signature domains are indicated.( B)
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highly conserved, while the N-terminal region is constituted of
amino acids specific to each Argonaute, especially prominent in
ALG-1. The N-terminus is involved in protein interactions which
confer specificity to ALG-1 [12].
The highly conserved orthologs of both genes that are readily
identified in other Caenorhabditis species (Fig. 1B) along with the
high alg-1 and alg-2 DNA sequence similarity, indicates that these
genes most probably arose by recent gene duplication as
previously suggested by Grishok and collaborators [6].
Expression pattern of ALG-1 and ALG-2
In order to investigate functional differences between alg-1 and
alg-2, we first examined their expression pattern using functional
translational reporters containing both ALG-1 and ALG-2 tagged
with GFP or RFP, preserving their endogenous promoters and
UTRs in the respective mutant backgrounds. For simplicity, we
refer to the GFP::ALG-2 and RFP::ALG-1 reporters as ALG-2
and ALG-1, respectively. Both Argonautes were found to be
broadly expressed in most tissues, but their expression patterns
were not completely overlapping. Subsets of neurons in the head
ganglia expressed predominantly ALG-2, while the pharynx more
prominently expressed ALG-1 (Fig. 2). Cells in the tail also
displayed specific expression. Nonetheless, both Argonautes are
expressed together in tissues including the vulva, seam cells,
ventral nerve chord and somatic gonad (Fig. 2, Table 1, Fig. S1
and Fig. S2). Identical ALG-1 expression was also observed for the
common tissues examined by Chan and Slack using similar
translational reporter [13]. To confirm that the expression pattern
observed with chromosomal arrays reflects the expression of
endogenous protein, we performed a whole-worm immunostain-
ings using a polyclonal antibody raised against the ALG-1 specific
N-terminus region (ALG-2 specific antibody is not yet available).
The endogenous ALG-1 expression was confirmed for the
pharynx and head neurons (Fig. S3) further supporting the
expression pattern observed with transgenic lines.
We next examined the ALG-1/2 expression in distinct C. elegans
stages. Examination of the ALG-1/2 expression during larval
development did not reveal differences in expression duringthe four
larval stages and adults (Fig. 3). However, during embryogenesis the
onset of zygotic expression was distinct. ALG-2 started to be
expressed from pre-morphogenetic embryonic stages while ALG-1
is first detected at the beginning of the morphogeneticphase (Fig. 4).
Altogether, our data indicated that the ALG-1/2 expression
patterns are spatially and temporally overlapping with some specific
tissues where one of the Argonautes is predominantly expressed.
microRNA interactions with ALG-1 and ALG-2
To complement theALG-1/2expression patterns,we studied the
association of a set of miRNAs with ALG-1 and ALG-2 throughout
the four larval stages (L1–L4). To achieve this, we first
immunoprecipitated ALG-1 and ALG-2 complexes from synchro-
nized larval populations of transgenic worms expressing either
ALG-1 or GFP::ALG-2 functional integrated transgenes (Fig. S4).
We next purified small RNAs from ALG-1/2 complexes and
determined miRNA association by microarrays. While control
immunoprecipitations do not show significant difference in miRNA
association (data not shown), at each stage of development, we
detected a number of miRNAs associated preferentially to ALG-1
or ALG-2 and notably this preferential association was higher in the
L1 and L4 stages compared to the L2/L3 stages (Fig. 5). The
relative association of miRNAs to the Argonautes at each
developmental stage followed a trend of conservation at other
stages, but for some miRNAs it changed dramatically during
development (e.g. miR-44 in L1 and L3 stages associates more with
ALG-1 while at L2 and L4 it does with ALG-2, miR-253 switched
its relative association from the L1/L2 stages to L3/L4). Therefore,
our analysis indicates that while ALG-1/2 largely bind to the same
set of miRNAs, the association of specific miRNAs to either
Argonaute supports the existence of specificity at the molecular or
cellular level that follows specific dynamics during development.
ALG-1/2 are required for embryonic morphogenesis
Although alg-1 and alg-2 are highly similar at the sequence level
and have mostly overlapping expression patterns, mutants of these
Argonautes differ substantially in their phenotypes. Comparison of
putative null alleles, reveals that alg-1(gk214) mutants have lesser
growth and fertility compared to alg-2(ok304) [14] and much more
penetrant miRNA-related phenotypes like gapped alae (alg-1 24%,
alg-2 0%, n=60) and bursting through the vulva (alg-1 27%, alg-2
0%, n=40). Besides these post-embryonic phenotypes, neither alg-
1(gk214) or alg-2(ok304) have detectable embryonic lethality under
standard growth conditions. To further precise the two Argonautes
embryonic phenotypes, a balanced strain with deletion alleles of
both genes was constructed (alg-2(ok304); alg-1(gk214)/unc-
84(e1410)). The strain segregated the expected genotypes but no
homozygous alg-2(ok304); alg-1(gk214) double mutants (hereafter
referred to as double mutants) were ever found as viable worms.
Indeed, homozygous double mutants arrested as embryos,
consistent with the phenotype observed in simultaneous RNAi
knockdown of alg- 1 and alg-2 [6].
The embryonic arrest of the double mutant indicates that at
least one of the two Argonautes has to be zygotically expressed in
the embryo to allow complete development. The double mutant
predominantly arrested at the 2-fold stage of development at 15
and 25uC (Fig. 6 and data not shown). This stage is part of the
morphogenetic phase of development, which follows after most
embryonic cell divisions have taken place and comprises major
shape changes and completion of organogenesis. The fraction of
embryos that arrested either after complete elongation or before
morphogenesis is possibly due to incomplete penetrance and
variation of the maternally contributed ALG-1 and ALG-2.
To further characterize the embryonic requirement of alg-1/2,
time-lapse microscopic recordings were conducted. We did not
detect developmental defects in the double mutants before the 2-
fold stage, and the recordings revealed no evident difference in
developmental timing between the double mutant embryos and
their viable siblings prior to the 2-fold stage were arrest occurred
(Fig. 7 and Movie S1). This supports that the 2-fold arrest is likely
caused by the disruption of one or various morphogenetic
processes taking place and not the consequence of an earlier
embryonic defect.
ALG-1 and ALG-2 requirement in epidermal cytoskeleton
and muscle development
The observed embryonic arrest may reflect an impairment of
one or several of the process taking place during the morphoge-
netic phase of development, namely epidermal migration, ventral
Neighbor joining tree of nematodes and human AGO-clade Argonautes based on the conserved sites from an alignment of full length protein
sequences. With the exception of human AGO1 and AGO3 (*), all the subtrees are robustly significant (higher than 95% bootstrap; 500 trials). Ce,
Caenorhabditis elegans; Cb, Caenorhabditis briggsae; Hs, Homo sapiens.
doi:10.1371/journal.pone.0033750.g001
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cells, initially located in the embryonic dorsal part, intercalate and
extend around the embryo towards the ventral side and fully
enclose it. Upon completion of epidermal enclosure, embryos
continue to elongate anteroposteriorly, a process whereby
epidermal and muscle cells actively drive the constriction of the
embryo along its cross-section. Examination of the epidermal
adherens junctions, as judged by staining with the junction-specific
monoclonal antibody MH27, did not reveal any apparent
epithelial polarity defect and revealed a minor epidermal cell
shape defect commonly found in embryos with partial or severe
muscle defects (data not shown). Consistent with DIC pictures
(Fig. 6), embryos could not elongate much beyond the two-fold
stage resulting in slightly deformed embryos (Fig. 8B). Thus,
proper epidermal specification, dorsal intercalation and ventral
enclosure are achieved in the double mutant embryos with very
few exceptions.
The elongation process depends on the concerted epidermal
and muscle function, and both tissues connect through specialized
junctions containing hemidesmosomes and intermediate filaments
(known as fibrous organelles) [16]. To investigate their integrity,
we co-stained embryos from alg-2(ok304); alg-1(gk214)/unc-
84(e1410) parents with a hemidesmosome marker (antibodies
against VAB-10A protein) and a monoclonal antibody against a
muscle marker (NE8/4C6). We observed that fibrous organelles
were interrupted, and that muscles appeared to detach from the
body wall in those areas in most putative alg-2(ok304); alg-1(gk214)
embryos: out of 80 embryos laid by heterozygous parents, 21 had
elongation defects (putative double mutants), 18 of which also
showed fibrous organelle and/or muscle defects (Fig. 8). However,
fibrous organelle defects were not as severe as in very strong
fibrous organelle mutants such as vab-10 and vab-19,o ri nvab-
10(e698); eel-1(ok1575) double mutants [17]. The muscle NE8/
Table 1. Summary of ALG-1 and ALG-2 expression in different
organs and tissues.
Tissue Abbrev. ALG-1 ALG-2
Intestine I ++
Pharynx P + 2
Head Hypodermis HH ++
Body Hypodermis BH ++
Tail Hypodermis TH ++
Seam cells SC ++
Excretory system X ++
Spermatheca S ++
Distal Tip Cells DTC ++
Uterus U ++
Gonadal Sheath GS ++
Vulva V ++
Body Neurons BN ++
Head Neurons HN 2 +
Tail Neurons TN ++
Body Muscle BM ++
Rectum R ++
Fluorescence intensity is indicated as + to indicate a discernible signal, and – if
signal was not clearly discernible from background fluorescence.
doi:10.1371/journal.pone.0033750.t001
Figure 2. ALG-1 and ALG-2 expression profile in adult worms.
Top panel: GFP::ALG-2 and RFP::ALG-1 are co-expressed in most
tissues including vulva (V) and spermatheca (S). Bottom panel:
Predominant GFP::ALG-2 expression is seen in a set of head neurons
(HN) and tail cells (T) while RFP::ALG-1 is strongly expressed in the
pharynx (P) and some tail cells (T). Scale bar 20 mm.
doi:10.1371/journal.pone.0033750.g002
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pat mutants which disrupt the attachment of myofibers to the
muscle plasma membrane [18].
Altogether our immunofluorescence data are consistent with the
time-lapse analysis and suggest that defective embryonic morpho-
genesis is the primary cause of lethality of the double mutant. The
penetrant fibrous organelle defect is compatible with either
disruption of a fibrous organelle component, or of a muscle
component.
Discussion
Our study indicates that the Argonaute encoding alg-1 and alg-2
genes have remarkable similarities that do not preclude major
Figure 3. Profile of ALG-1 and ALG-2 expression in larval stage. Expression profile of GFP::ALG-2 and RFP::ALG-1 as seen in the L1 larval stage.
Subsequent larval stages (L2 to L4) and adults display the same expression profile (not shown). Scale bar 20 mm.
doi:10.1371/journal.pone.0033750.g003
Figure 4. Embryonic ALG-1 and ALG-2 expression. The expression onset of GFP::ALG-2 and RFP::ALG-1 differs. RFP::ALG-1 fluorescence is first
detected at the beginning of the morphogenetic phase (B). Scale bar 20 mm.
doi:10.1371/journal.pone.0033750.g004
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quence homology, overlapping expression patterns, partially
coincident sets of bound miRNAs, and their redundant require-
ment for embryonic development. However, single mutant of
these genes lead to very distinct phenotypes and effects on the
miRNA pathway during worm post-embryonic stages. The more
penetrant defects seen in alg-1 mutants do not correlate with
differences in the relative abundance of ALG-1/2, as judged by
western analysis using antibody against the conserved region of
ALG-1/2 ([19]; unpublished observations).
The detailed analysis of the expression pattern of alg-1 and alg-2
demonstrates that ALG-1/2 proteins are overlapping in many
tissues, but a specific expression pattern is observed in a subset of
head neurons, pharynx and specific cells in the tail. The
embryonic onset of expression differs and leads to a pattern that
remained constant from the first larval stage to adults. The
differences in the alg-1/2 expression patterns may result in part
from transcriptional differences. Genome-wide analysis of the
transcription factor PHA-4 has found that it binds to the alg-1
promoter, while no significant binding is detected in the promoter
Figure 5. Relative microRNA association with ALG-1 and ALG-2. Heatmaps representing the ratios of ALG-1 to ALG-2 associated miRNAs at
the larval stages indicated as estimated from miRNA microarrays (towards red: stronger association to ALG-2, towards green: stronger association to
ALG-1). miRNA expression data were filtered for robustly expressed miRNAs. Ratios were log2 transformed, centered and normalized for each column.
The distance of the solid blue line from the center of each color-cell is proportional to the ratio. Mean ratio indicated as dotted blue line.
doi:10.1371/journal.pone.0033750.g005
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additional transcription factors may contribute to the specificity of
the alg-1/2 expression in certain tissues.
In agreement with the observed expression overlap, miRNA
profiling during the worm larval stages showed that ALG-1/2 bind
the studied set of miRNAs coincidently although a preferential
association is detected for some miRNAs. Similar miRNA-
Argonaute associations have also been observed for human
Argonautes in cultured cells [21]. This preferential association
could arise in two ways, differential co-expression of Argonaute
and miRNA in certain cells, or as result of molecular Argonaute-
miRNA specificity. It should be noticed that observed preferential
association of some miRNAs to ALG-1/2, does not constitute an
exclusive association that would make specific miRNAs completely
dependent on the presence of either ALG-1 or ALG-2.
In a first scenario, the co-expression of a specific Argonaute and
miRNA could increase their relative association. The expression of
many C. elegans miRNAs has been described [22,23,24] and ranges
from highly specialized (i.e. lsy-6) to widely expressed. The
presence of specific tissues where one of the alg-1/2 is
predominantly expressed, and the specialized expression seen in
some miRNAs could dictate specific miRNA-ALG-1/2 interac-
tions in certain cells or tissues. The correlation of miRNA and
ALG-1/2 expression is subject to confounding effects given that
the relative association we measured reflects the contribution of all
the tissues were the miRNA is expressed. In few cases a correlation
is straightforward, ALG-2 is predominantly expressed in neurons
of the head ganglia, and it associates preferentially with the miR-
72 miRNA that is expressed only in the head neurons [22].
Alternatively, molecular specificity may explain preferential
miRNA-Argonaute association. The identity of the 59 terminal
nucleotide confers affinity on small RNAs for different plant
Argonautes [25], and duplex mismatches sort out siRNA and
miRNA in flies and C. elegans [26,27,28]. However, it is yet
unknown what could determine the specificity of Argonaute
proteins for particular miRNAs. The sequence and structure of
miRNAs and their precursors molecules as well as Argonautes
interactions with additional factors could potentially confer this
specificity. This kind of features may potentially explain the
relative association observed among ubiquitously expressed
miRNAs such as miR-52 and miR-71 that are associated
preferentially with ALG-2 and ALG-1, respectively.
Our observations also demonstrate that genetically, alg-1/2
share functions during embryonic development. The embryonic
lethality of the alg-1/2 double mutant is not observed in single
mutants of Dicer and Drosha, due to the fact that the maternal
contribution of these enzymes of the microRNA pathway allows
homozygous mutants to complete all developmental stages and
become sterile adults [29,30]. In contrast, the embryonic lethality
of the double mutant reveals that alg-1/2 maternal contribution is
insufficient to complete development, and thus zygotic expression
is required. The alg-1/2 maternal contribution [31] present in the
double mutant, disallowed the examination of the ALG-1/2 role
during early development. An early developmental role for specific
miRNAs and associated Argonautes in the degradation of
maternal transcripts at the maternal to zygotic transition has been
documented in zebrafish [32] and the X. laevis [33], and could be
explored in C. elegans by using RNAi. Considering that alg-1/2
function in the miRNA pathway and that most miRNAs are not
essential for development [34,35], the observed embryonic arrest
may be the result of the combined loss of a specific set of miRNAs.
To date, the absence of the complete mir-35 and mir-52 families
has been reported as embryonic lethal. The loss of miR-35 family
causes a slower development and arrest at the 2-fold to 3-fold stage
[35], while the miR-52 family mutant displays unattachment of
the pharynx at a late stage of embryonic development [36].
Identification of the miRNAs and targeted genes involved in the
embryonic arrest remains open for future work.
Beside C. elegans, mutants of the miRNA Argonautes in
mammals and Drosophila also display embryonic lethality. Ago2
knockout mice display early mesoderm defects [37,38], as well as
mid-gestational death due to placental defects [7,39]. Similarly,
ago1 and ago2 are together essential for the establishment of
segment polarity in flies [40]. Some of these essential develop-
mental roles of the miRNA pathway during animal development
may reflect a common requirement of the pathway for the proper
differentiation and function of certain tissues. Along this line, our
data demonstrate the requirement of alg-1/2 during the morpho-
genetic phase of embryonic development, manifested through the
predominant arrest at the 2-fold stage, where worms are unable to
complete the elongation process. For the most part, the epidermal
and muscle tissues of the double mutant embryos are properly
specified and epidermal adherens junctions presumably normal. In
contrast, the epidermal-muscle attachment structures are mildly
but frequently affected. The defects most likely stem from
epidermal fibrous organelle or muscle defects. Since both the
elongation defects and fibrous organelle staining defects were less
severe than those observed in core fibrous organelle mutants, we
do not think that ALG-1 and ALG-2, hence that miRNAs, are
essential for the production of a core fibrous organelle component.
We recently established that muscle contractions are required to
Figure 6. ALG-1 and ALG-2 are required for C. elegans
embryonic development. Statistics of embryonic arrest at 15uC
(n=272). Freshly layed eggs on petri dishes were examined after a
period of 12 h. A major fraction of double mutant embryos arrest
during the morphogenetic phase of development (B–D), mainly at the
2-fold stage (B).
doi:10.1371/journal.pone.0033750.g006
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[41]. Hence, one or more miRNAs might contribute either to
some aspect of muscle differentiation and/or contractility, or
within the epidermis to relay the muscle-to-epidermis mechanical
signal, possibly in a feedback loop. Future experiments should help
clarify among those possibilities.
Materials and Methods
Culture conditions and general methods
Worms were cultured in standard conditions [42]. All
experiments were performed at 20uC unless otherwise noted.
Transgenic strains
The following transgenic strains were generated by microin-
jecting mix of plasmids and UV integrated as described in [43,44]:
MJS13: alg-1(gk214) In[alg-1p::rfp::alg-1::alg-1 39UTR ;
alg-2p::gfp::alg-2::alg-2 39UTR ; pRF4]
MJS18: alg-2(ok304) In[alg-1p::gfp::alg-1::alg-1 39UTR ;
alg-2p::rfp::alg-2::alg-2 39UTR ; pRF4]
MJS46: alg-1(gk214) In[alg-1p::alg-::alg-1 39UTR ;
pRF4]
MJS26: alg-2(ok304) In[alg-2p::gfp::alg-2::alg-2 39UTR ;
pRF4]
Figure 7. Developmental timing of double alg-1/2 mutant and siblings. Time-lapse microscopy of C. elegans embryos. Both embryos proceed
through development at similar rates until the morphogenetic phase (375 min) were the alg-2(ok304); alg-1(gk214) double mutant arrest (asterisk).
Viable siblings were able to proceed development normally. The double mutant embryos are not paralyzed and are able to twitch (see Movie S1).
doi:10.1371/journal.pone.0033750.g007
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Worms were examined mounted on agar pads using a Zeiss
axioimager M1 microscope.
Time-lapse recordings were done using the AxioVision (Release
4.8) software at 1 minute interval during 600 minutes.
Immunostainings
For embryo stainings, heterozygous alg-2(ok304); alg-1(gk214)/
unc-84(e1410) mothers were propagated at 25uC (non-permissive
for unc-84) and allowed to lay eggs for 2-hour intervals. Embryos
were collected, fixed and immuno-stained with mAb MH27
(DSHB, University of Iowa; recognizing AJM-1) and polyclonal
LIN-26 antibodies (epidermal nuclei; Labouesse et al, 1996), or
with the mAb NE8-4C6 (muscle marker; Schnabel, 1995) and
polyclonal 4F2 antibodies (against VAB-10A; Bosher et al , 2003)
as described elsewhere (Bosher et al, 2003). The NE8/4C6
monoclonal antibody was provided by the Medical Research
Council. Stacks of images every 0.3 mm were captured using a
confocal microscope (Leica SP2 AOBS RS); generally 10 confocal
sections were projected using ImageJ and then processed using
Adobe Photoshop.
For whole worm staining, mix-staged worms were collected and
washed extensively several times with M9 buffer and staining was
performed as by [45]. Fixed and permeabilized animals were
incubated overnight at 4uC with purified rabbit anti-ALG-1
antibody (1:100) and probed with Alexa Fluor 488 anti-rabbit
(1:500) (Molecular Probes) as secondary antibody for 4 hours at
room temperature. Images were captured using Zeiss motorized
Axioplan 2 microscope at 6306with an AxioCam MRm camera
and AxioVision acquisition software.
Figure 8. ALG-1/2 function is required to maintain muscles and the epidermis. (A–B) Embryos collected between 6–8 hours post egg-
laying at 25uC and stained with the antibodies MH27 (adherens junction). The alg-1; alg-2 mutant embryo did not progress beyond the two-fold
stage, yet has grossly normal junctions. (C–E) Embryos collected between 6–8 hours post egg-laying at 25uC and stained with the antibodies 4F2
(VAB-10A; C–E) and NE8/4C6 (muscle; C9–E9); merge picture (C0–E0). Arrow, are where the fibrous organelle (D–E) and muscle (D9–E9) pattern is
partially interrupted; in addition, muscles do not closely follow the body wall in this area (they should be closer to the blue dotted line; see blue
arrowheads). Embryos did not elongate beyond the two-fold stage.
doi:10.1371/journal.pone.0033750.g008
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The transgenic animals expressing integrated arrays of either
ALG-1 or GFP::ALG-2 tagged protein were harvested at specific
development stages corresponding to four different larval transi-
tions and total protein lysates were prepared as described
previously [12]. Protein lysates prepared from alg-1 (gk214) and
for wild-type N2 animals were used as controls for ALG-1 and
GFP::ALG-2, respectively. Immunoprecipitations were performed
by preclearing 4 mg of total protein with 20 ml of protein-G
magnetic beads (invitrogen) for 1 h at 4uC. The cleared lysates
were then incubated for 2 h at 4uC with 20 mL of protein-G
magnetic beads conjugated with either 5 mg of affinity-purified
polyclonal anti-ALG-1 antibody [14] or with the monoclonal
antibody anti-AFP 3E6 (QBiogene). The beads were then washed
three times with ice-cold lysis buffer containing 1% of Superasin
(Roche). 90% of the purified beads were used for total RNA
extraction performed as described in [46]. The remaining 10% of
beads were boiled in SDS loading buffer and protein resolved by
SDS-PAGE on an 8% gel. To detect ALG-1 and GFP-tagged
ALG-2, the membranes were incubated overnight at 4uC with
either affinity-purified polyclonal anti-ALG-1 diluted 1:5000 or a
mouse monoclonal anti-GFP (Roche) diluted 1:2000 in TBST-
milk solution, incubated 1 h at room temperature with either anti-
rabbit (ALG-1) or anti-mouse (GFP-ALG-2) HRP-conjugated
secondary antibody and then visualized by Western Lightening
ECL Kit (Perkin Elmer).
RNA molecules extracted from ALG-1 and ALG-2 complexes
were then subjected to size selection and purified small RNAs were
used for miRNA array profilings as performed in [47]. All miRNA
expression data have been submitted to the Gene Expression
Omnibus (GEO) with accession number GSE35505 (for micro-
array platform used).
Supporting Information
Figure S1 ALG-1 and ALG-2 expression profiles.
GFP::ALG-2 and RFP::ALG-1 expression in body neurons (BN),
seam cells (SC), excretory system cell (X), uterine cells lining the
uterine cavity (U) and gonadal sheet cells (GS). Scale bar 20 mm.
(TIF)
Figure S2 ALG-1 and ALG-2 expression profiles.
GFP::ALG-2 and RFP::ALG-1 expression in head hypodermal
cell (HH), tail hypodermal cells and tail neurons (TH,TN), body
muscle cells (BM) and larval P cells whose lineage contribute to the
neurons and body hypodermis (BH). Scale bar 20 mm.
(TIF)
Figure S3 Immunostaining of ALG-1 in adult C. elegans
hermaphrodites. Staining with polyclonal antibody against
ALG-1 of head organs. (A) A specific signal is detected in the
pharynx of wild-type animals. (B) Staining of control alg-1(gk214)
animal.
(TIF)
Figure S4 Detection of ALG-1 and GFP::ALG-2 in
purified complexes. Detection of ALG-1 (A) and GFP::ALG-
2 (B) by Western blot analysis found in the immunopurified (IP)
complexes from each developmental stage used for microRNA
microarrays. 50 mg of the total protein (in) were run as controls.
(TIF)
Movie S1 Time-lapse analysis of the alg-2(ok304); alg-
1(gk214)/+ embryos. Movie from the time-lapse microscopy
shown in Figure 7. The double mutant alg-2; alg-1 embryo is
located at the bottom.
(MP4)
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